TA147: Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal)
This is a discussion on TA147: Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal) within the Updates from the Technology Assessment Authorities forum, part of the Industry News and Updates category; The summary for the published technology appraisal on Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal). It links to the ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
04-01-2010, 12:51 PM
|
|||
|
|||
TA147: Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal)
The summary for the published technology appraisal on Breast cancer (advanced & metastatic) - bevacizumab (terminated appraisal). It links to the published guidance and key documents.
More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| TA118: Colorectal cancer (metastatic) - bevacizumab & cetuximab | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA148: Lung cancer (non-small-cell) - bevacizumab (terminated appraisal) | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA149: Glioma (recurrent) - carmustine implants (terminated appraisal) | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA150: Colorectal cancer (metastatic) - cetuximab (terminated appraisal) | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
| TA175: Lung cancer (non-small-cell, second line) - gefitinib (terminated appraisal) | industry_news | Updates from the Technology Assessment Authorities | 0 | 04-01-2010 12:51 PM |
© 2008 DrugManagementForum™ powered by |
 |